FDA Drug recall D-0107-2017
Dream Body 450 mg 30 capsules in a plastic screw on top bottle
- FDA Drug
- Class II
- terminated
- Published 2016-10-26
On 2016-10-26 the FDA classified a Class II recall of Dream Body 450 mg 30 capsules in a plastic screw on top bottle by Dream Body Weight Loss, citing marketed without an approved NDA/ANDA: Undeclared sibutramine.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0107-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-07-01 |
| Published | 2016-10-26 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Dream Body Weight Loss |
| Distribution | n/a |
Product
Dream Body 450 mg 30 capsules in a plastic screw on top bottle
Reason
Marketed without an approved NDA/ANDA: Undeclared sibutramine.
Identifiers
| code_info | All lots. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0107-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.